Atlas Trials

Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients

Clinical trial NCT03643133 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03643133
Sponsor
UNICANCER
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Osteosarcoma
Start date
2018-10-23
Primary completion
2026-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.